Brings extensive experience in patient care, dermatologic research and commercializationKing of Prussia, Pennsylvania--(Newsfile Corp. - July 21, 2026) - Phio...
Seasoned executive leader and physician-scientist brings deep immunology and transplant medicine experienceCompany strengthens executive team as it advances its lead ex...
High-Octane Partnership: Multi-time X Games medalist Jarryd McNeil joins BUZZ BOMB™ to fuel brand expansion in action sports.Consumer Connection: The...
HOLON, Israel, July 20, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a...
CUVL to trade on the highest tier – Global Select MarketMELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE)...
"After Years of Warning Investors That Their Business Violated Federal Law, America's Largest Cannabis Companies Are Now Betting Everything on...
After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden...
After years of riding for the people she loved, recently diagnosed breast cancer patient Heidi Panych returns to the road...
Rhelion Life Sciences reflects the Company's evolution into a sharpened focused, science-driven life sciences platform dedicated to psychedelic drug discovery,...
Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist...
Boehringer headquarters Boehringer headquarters, Ingelheim, Germany Not intended for UK and US audiences JASCAYD® (nerandomilast) is the first oral, preferential PDE4B...
Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in...
Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven disorders Concurrent...
Transaction positions the combined company to execute a capital-efficient, repeatable strategy leveraging public market access and Lōkahi Therapeutics ai²-driven asset...
Trial court denied Company’s motion for a new trial and judgment as a matter of law for unjust enrichmentANI intends...
250 participants enrolled in less than five months from first participant dosing, representing the fastest site activation and enrolment in...
WhatToTrust™ honored for its science-based approach to consumer dietary supplement educationROCHESTER, Minn., July 16, 2026 /PRNewswire/ -- Canomiks has received...
NEW YORK, July 16, 2026 /PRNewswire/ -- Canopy, the leader in Enterprise AI for oncology, today announced a multi-year partnership...
HAMPTON, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that Sam Martin, Senior Vice President and Chief...
First GLP-1 pill approved in the European Union for the treatment of obesity and overweightOnly Wegovy® pill demonstrates 17%* mean...